Japan’s Takeda Pharmaceutical Co Ltd said on Friday China’s market regulator had approved its $62 billion acquisition of Shire Plc , bringing it closer to becoming a global top 10 drugmaker.
Source:: Reuters – Business News
Japan’s Takeda Pharmaceutical Co Ltd said on Friday China’s market regulator had approved its $62 billion acquisition of Shire Plc , bringing it closer to becoming a global top 10 drugmaker.
Source:: Reuters – Business News
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.